The Emerging Role of Biosimilars in Value-Based Medicine
01 Dec 2022
Biologic medicines and biosimilars
Biologic medicines are a category of very specific, highly effective medicines produced by a sophisticated and complex process involving living system1. Most of them are very large, complex molecules or mixtures of molecules, and many are produced using recombinant DNA technology. These medicines have revolutionised the treatment and prevention of many disabling and life-threatening diseases including cancers, Crohn’s disease, ulcerative colitis, diabetes, rheumatoid arthritis, osteoporosis, psoriasis, human immunodeficiency virus, multiple sclerosis, growth deficiencies, and more1.
Biologic medicines are a category of very specific, highly effective medicines produced by a sophisticated and complex process involving living system1. Most of them are very large, complex molecules or mixtures of molecules, and many are produced using recombinant DNA technology. These medicines have revolutionised the treatment and prevention of many disabling and life-threatening diseases including cancers, Crohn’s disease, ulcerative colitis, diabetes, rheumatoid arthritis, osteoporosis, psoriasis, human immunodeficiency virus, multiple sclerosis, growth deficiencies, and more1.
Resources
The Emerging Role of Biosimilars in Value-Based Medicine
The Emerging Role of Biosimilars in Value-Based Medicine